MYTTON OAK MEDICAL PRACT. — All Prescriptions & Medications — Page 2
Practice Code: M82002 | SHREWSBURY, SY3 5LZ
Showing results 51-100 of 598
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Candesartan cilexetil | 713 | 39.9K | £2.1K | -39.9% ▼ |
| Gabapentin | 708 | 78.2K | £6.0K | -29.1% ▼ |
| Other emollient preparations | 704 | 425.4K | £5.3K | +17.2% ▲ |
| Amoxicillin | 701 | 32.1K | £918 | -24.8% ▼ |
| Bendroflumethiazide | 680 | 39.2K | £664 | -12.1% ▼ |
| Naproxen | 662 | 33.5K | £1.5K | -32.9% ▼ |
| Morphine sulfate | 657 | 58.1K | £3.7K | +0.2% vs avg |
| Quetiapine | 644 | 34.2K | £12.9K | +3.4% ▲ |
| Isosorbide mononitrate | 633 | 43.1K | £5.5K | -4.2% ▼ |
| Progesterone | 623 | 56.5K | £11.0K | +48.8% ▲ |
| Lamotrigine | 617 | 53.4K | £7.4K | +4.5% ▲ |
| Hydroxocobalamin | 606 | 716 | £1.5K | +25.9% ▲ |
| Gliclazide | 591 | 52.5K | £1.5K | -30.5% ▼ |
| Ezetimibe | 575 | 29.4K | £5.2K | -19.2% ▼ |
| Tramadol hydrochloride | 551 | 55.2K | £2.1K | -23.1% ▼ |
| Ferrous sulfate | 551 | 31.3K | £1.0K | +7.2% ▲ |
| Carbocisteine | 549 | 83.8K | £2.8K | +2.8% ▲ |
| Diazepam | 543 | 18.2K | £401 | +9.0% ▲ |
| Warfarin sodium | 532 | 41.5K | £1.4K | +12.8% ▲ |
| Fluticasone propionate (Inhalation) | 518 | 837 | £18.8K | +33.9% ▲ |
| Flucloxacillin sodium | 509 | 20.9K | £1.1K | +13.2% ▲ |
| Latanoprost | 506 | 17.0K | £5.1K | +4.2% ▲ |
| Nitrofurantoin | 500 | 6,508 | £2.9K | +4.8% ▲ |
| Desogestrel | 461 | 55.4K | £1.6K | +16.3% ▲ |
| 459 | 58.3K | £3.9K | +112.2% ▲ | |
| Sildenafil (Erectile Dysfunction) | 443 | 2,784 | £403 | -12.1% ▼ |
| 443 | 46.7K | £1.7K | +546.8% ▲ | |
| Hydrocortisone | 440 | 13.3K | £3.8K | -1.9% vs avg |
| Solifenacin | 438 | 20.6K | £1.7K | -8.2% ▼ |
| 430 | 10.2K | £4.1K | -35.3% ▼ | |
| Atenolol | 427 | 26.2K | £575 | -29.2% ▼ |
| Insulin aspart | 427 | 2,606 | £17.3K | +12.1% ▲ |
| 423 | 234.6K | £2.8K | +60.3% ▲ | |
| Budesonide | 416 | 1,767 | £16.7K | -23.2% ▼ |
| Betamethasone valerate | 413 | 37.0K | £2.3K | +7.3% ▲ |
| Glucose blood testing reagents | 395 | 40.2K | £7.0K | -49.9% ▼ |
| Digoxin | 383 | 16.0K | £1.2K | +1.2% vs avg |
| Methotrexate | 380 | 8,212 | £500 | +16.8% ▲ |
| Estradiol | 362 | 10.1K | £4.9K | +34.2% ▲ |
| Indapamide | 361 | 18.9K | £843 | -58.1% ▼ |
| Spironolactone | 358 | 14.3K | £1.2K | -33.6% ▼ |
| Finasteride | 358 | 16.0K | £563 | -45.3% ▼ |
| Rivaroxaban | 354 | 17.0K | £11.2K | -42.1% ▼ |
| Memantine hydrochloride | 354 | 12.0K | £2.3K | +7.2% ▲ |
| Mometasone furoate | 353 | 393 | £3.0K | -12.1% ▼ |
| Cetirizine hydrochloride | 347 | 29.3K | £1.4K | -30.6% ▼ |
| Insulin glargine | 347 | 2,052 | £17.4K | +22.2% ▲ |
| Sitagliptin | 347 | 16.0K | £1.1K | -11.0% ▼ |
| Lidocaine hydrochloride | 346 | 3,959 | £1.3K | +100.6% ▲ |
| Diltiazem hydrochloride | 335 | 21.3K | £3.4K | +9.1% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.